Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FAZKS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $135,839
Award facts
- Contract value 100% obligated
- $135,838.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $135,838.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200-unit vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and was awarded on September 15, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on a competitive basis leveraging its established status within federal procurement markets.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.99 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs and specialty medications to Department of Defense healthcare sites. The Botox supply under this delivery order supports the medical needs of military health facilities and represents part of the company's extensive portfolio of pharmaceutical deliveries to federal agencies, which includes biologics, branded and generic prescription drugs, and specialized injectable products.
Quick answers
Who was awarded contract SPE2DB25FAZKS?
SPE2DB25FAZKS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FAZKS worth?
The government has obligated $135,839 on SPE2DB25FAZKS.
Is contract SPE2DB25FAZKS an order under another contract?
Yes. SPE2DB25FAZKS is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB25FAZKS competed?
The extent of competition for SPE2DB25FAZKS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award